Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH

20.27

+0.08(+0.40%)

Updated at January 14 03:00PM

Currency In CNY

Valuation

Market Cap3.19B
Enterprise Value3.06B
P/E Ratio19.93
PEG Ratio6.58
Price/Sales Ratio5.71
Price/Book Ratio2.08
Enterprise/Revenue5.56
Enterprise/EBITDA17.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.28
Operating Margin0.3

Management Effectiveness

Return On Assets0.09
Return On Equity0.11

Income Statement

Revenue555.59M
Revenue/Share3.58
Gross Profit242.32M
EBITDA196.9M
Net Income124.21M
Diluted EPS0.74

Balance Sheet

Total Cash258.22M
Total Cash/Share1.55
Total Debt104.66M
Total Debt/Equity0.06
Current Ratio5.79
Book Value Per Share9.83

Price History

52-Week Change10.04
52-Week High31.13
52-Week Low18.08
Moving Average 50 Days23.28
Moving Average 200 Days25.22

Statistics

Average Volume2.99M
Shares Outstanding168.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.99
Payout Ratio0.01
Last Split Factor7:5
Last Split DateJuly 18, 2023